Podcasts about md phd

The CME experience for this Podcast is powered by CMEfy - click here to reflect and unlock credits & more: https://earnc.me/qMMXwq   Diana M. Girnita, MD, PhD is the CEO& Founder of Rheumatologist OnCall , a telemedicine company that provides specialized services to patients in multiple US states. Rheumatologist OnCall broadens the access to a top expert rheumatologist for patients with autoimmune diseases and arthritis. Access to specialists is delayed in our days up to 6 months. Rheumatologist OnCall offers quick access to top expert specialist care at affordable and transparent pricing to patients in eight US states.  The approach to patients is comprehensive and includes evidence-based medicine, but also provides nutrition, mindfulness and physical therapy services.  Dr. Girnita is a strong advocate for digital health, and telemedicine. She is also a nationwide promoter of practicing direct care as a specialist, to reduce costs and promote price transparency in healthcare. She is the Co-Founder of Direct Specialty Care Alliance and co-leader of the Free Market Medical Association California Chapter. Group Coaching for Physicians MD Coaches is proud to offer Group Coaching for Physicians. This is a small, intimate virtual group that will help to inspire participants to experience personal and professional fulfillment. Sessions begin on Thursday, October 6th, 2022 and runs through November 10th, 2022.  You will also earn CME credits by participating! For more information or to register please visit us at mdcoaches.store   Join the Conversation! We want to hear from you! Do you have additional thoughts about today's topic? Do you have your own Prescription for Success? Record a message on Speakpipe   All The Tools You Need To Build and Scale A Integrative Health Business Get a behind the scenes look at our playbook at Texas Center for Lifestyle Medicine to see the underpinnings of how they deliver health while keeping team members fulfilled. Find out more at https://rxforsuccesspodcast.com/IPB Unlock Bonus content and get the shows early on our Patreon Follow us or Subscribe: Apple Podcasts | Google Podcasts | Stitcher | Amazon  | Spotify --- Show notes at https://rxforsuccesspodcast.com/122 Report-out with comments or feedback at https://rxforsuccesspodcast.com/report Music by Ryan Jones. Find Ryan on Instagram at _ryjones_, Contact Ryan at ryjonesofficial@gmail.com

McGinley Orthopedics (MO) develops innovative engineering solutions for surgical procedures. In this Episode Adam Torres and Joseph McGinley, MD PhD, Founder & CEO of McGinley Orthopedic Innovations, they explored the McGinley Orthopedic story and mission to engineer medical technologies which improve patient care by reducing costs while improving safety.Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.Apply to be a guest on our podcast:https://missionmatters.lpages.co/podcastguest/Visit our website:https://missionmatters.com/

M4s Nathen and Zack, M3 Rick, and MD/PhD student Riley offer their ideas on prepping for residency interviews and the questions they'll probably be asked. Dave offers up an 'educational' improv exercise to help them prepare. Premed listener Emily was told that Family Medicine is a dead end...by her mom who is a Family Medicine doc! That's not really the case, is it?

Go online to PeerView.com/QSD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in Rett syndrome discusses the diagnosis and management of this rare disease, as well as the latest data on emerging treatment options. A 3D animation offers an overview of MECP2 mutation, hypothesized to be a major contributor to the CNS manifestations of Rett syndrome. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in infants demonstrating subtle signs and symptoms; Implement consensus recommendations on the age-specific management of patients with Rett syndrome; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of emerging pharmacologic treatment options to consider implementing these novel therapies when they become available.

Go online to PeerView.com/QSD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in Rett syndrome discusses the diagnosis and management of this rare disease, as well as the latest data on emerging treatment options. A 3D animation offers an overview of MECP2 mutation, hypothesized to be a major contributor to the CNS manifestations of Rett syndrome. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in infants demonstrating subtle signs and symptoms; Implement consensus recommendations on the age-specific management of patients with Rett syndrome; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of emerging pharmacologic treatment options to consider implementing these novel therapies when they become available.

Go online to PeerView.com/QSD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in Rett syndrome discusses the diagnosis and management of this rare disease, as well as the latest data on emerging treatment options. A 3D animation offers an overview of MECP2 mutation, hypothesized to be a major contributor to the CNS manifestations of Rett syndrome. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in infants demonstrating subtle signs and symptoms; Implement consensus recommendations on the age-specific management of patients with Rett syndrome; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of emerging pharmacologic treatment options to consider implementing these novel therapies when they become available.

Go online to PeerView.com/QSD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in Rett syndrome discusses the diagnosis and management of this rare disease, as well as the latest data on emerging treatment options. A 3D animation offers an overview of MECP2 mutation, hypothesized to be a major contributor to the CNS manifestations of Rett syndrome. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in infants demonstrating subtle signs and symptoms; Implement consensus recommendations on the age-specific management of patients with Rett syndrome; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of emerging pharmacologic treatment options to consider implementing these novel therapies when they become available.

McGinley Orthopedics (MO) develops innovative engineering solutions for surgical procedures. In this Episode Adam Torres and Joseph McGinley, MD PhD, Founder & CEO of McGinley Orthopedic Innovations, they explored the McGinley Orthopedic story and mission to engineer medical technologies which improve patient care by reducing costs while improving safety.Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.Apply to be a guest on our podcast:https://missionmatters.lpages.co/podcastguest/Visit our website:https://missionmatters.com/The Future Is FreelanceThis show is for freelancers, sole traders, solopreneurs, digital nomads, consultants,...Listen on: Apple Podcasts Spotify

Go online to PeerView.com/QSD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in Rett syndrome discusses the diagnosis and management of this rare disease, as well as the latest data on emerging treatment options. A 3D animation offers an overview of MECP2 mutation, hypothesized to be a major contributor to the CNS manifestations of Rett syndrome. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in infants demonstrating subtle signs and symptoms; Implement consensus recommendations on the age-specific management of patients with Rett syndrome; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of emerging pharmacologic treatment options to consider implementing these novel therapies when they become available.

Go online to PeerView.com/QSD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in Rett syndrome discusses the diagnosis and management of this rare disease, as well as the latest data on emerging treatment options. A 3D animation offers an overview of MECP2 mutation, hypothesized to be a major contributor to the CNS manifestations of Rett syndrome. Upon completion of this activity, participants should be better able to: Apply diagnostic criteria to provide a timely diagnosis of Rett syndrome in infants demonstrating subtle signs and symptoms; Implement consensus recommendations on the age-specific management of patients with Rett syndrome; and Evaluate the evidence surrounding the safety, efficacy, and tolerability of emerging pharmacologic treatment options to consider implementing these novel therapies when they become available.

This week we discuss mitochondrial DNA and its importance in aging with Amy Vandiver (@AmyVandiver2). We also highlight a new method to quickly sequence full length mitochondrial DNA allowing for mitochondrial genome comparisons and the understanding of the diversity between mitochondrial DNA. As usual we also discuss the process of pre-printing, preLights and how they can generate collaborations. As well as understanding more about the MD PhD group leader route. Read the full preprint: https://www.biorxiv.org/content/10.1101/2022.02.23.480720v2.full This episode was produced by Emma Wilson and edited by Jonny Coates. Use the code “jonny” to get free access to an online course all about preprints: https://courses.karger.com/courses/take/how-to-decide-on-preprints-and-open-access-licence/texts/28775362-introduction If you enjoyed this show then hit that subscribe button and leave a review (on Apple Podcasts or Spotify). If you love what we are trying to do then buy us a coffee https://www.buymeacoffee.com/preprints! Any contribution is greatly appreciated. For the latest podcast news and updates follow us on Twitter @MotionPod or visit our website; www.preprintsinmotion.com. Produced by JEmJ Productions (find us on Twitter: Jonny @JACoates, Emma @ELWilson92, John @JohnDHoward8) and generously supported by ASAPbio (https://asapbio.org | @asapbio_). Any additional sound effects used are from https://www.zapsplat.com.

On this week's episode, Jamie and Guy welcome a very special guest, Dr. Leonard Sax MD PhD.  Dr. Sax graduated Phi Beta Kappa from MIT at the age of 19.  He then went on to the University of Pennsylvania, where he earned both a PhD in psychology and an MD.  He has been continuously certified by the American Board of Family Medicine since 1989. He is also a New York Times Bestselling author and has written 4 books about child development and parenting: The Collapse of Parenting, Boys Adrift, Girls on the Edge, and Why Gender Matters. On today's episode, Jamie and Guy discuss the growing gender gap between boys and girls in education (and motivation in school) and how this has been widening over the last 40 years.  From changes in schools that cause disengagement from boys, to video games, to fewer boys getting college degrees, Dr. Sax discusses the causes and what we can do as parents to help our boys succeed. To learn more about Dr. Sax and his books, go to his website: https://www.leonardsax.com/  The following are links to his four books:Boys Adrifthttps://amzn.to/3RVVHVaThe Collapse of Parentinghttps://amzn.to/3R29xE5Girls on the Edgehttps://amzn.to/3DBISuUWhy Gender Mattershttps://amzn.to/3DUiWLpWe hope you enjoyed this episode - if you do, please take a minute to subscribe and leave a review on Apple Podcasts:) Thanks so much!Support the show (https://www.patreon.com/thedavenport)Join us on  Facebook :https://www.facebook.com/thedavenportpodcast/ Follow  us on Instagram:@thedavenportpodcast About  Jamie and Guy:Jamie Pyatt LCSW  is a mom, avid beach lover, exercise enthusiast, and a licensed clinical therapist with over 20 yrs of experience. She has worked in hospice care, child abuse intervention, and was an adoption facilitator for 13 years. Jamie loves working with individuals, couples, and teens as they embrace their personal stories and surf the daily waves of life. She makes friends wherever she goes and has a laugh that brightens any room. She believes each one of us deserves love, happiness, and connection ❤️Get to know Jamie better @therealjamiepyatt Guy  Balogh is a father of three, car enthusiast, an entrepreneur and small business owner (shout out to @holsterbrands), and a professional business and life coach. Guy loves working with individuals to think bigger, take risks, and maximize opportunities. His quick wit and talent for storytelling pair well with his desire to find the positive in any situation. Get to know Guy better   @therealcoachguySupport the show

Christopher Bunick, MD, PhD, LiVDerm faculty and member of the SBS Planning Committee, shares key takeaways from his session at the SBS 2022 event regarding IL-13 inhibitors for treatment of AD and the underlying disease pathogenesis.   With the several ongoing advances in the availability of more treatment options for managing atopic dermatitis, how can the practicing clinician best select the most appropriate treatment option that will address the underlying causes of disease progression? As with most treatment options for chronic conditions, side effects often occur. What considerations should clinicians remember when discussing treatment-related adverse events with their patients? Atopic dermatitis is stated to impact several areas of a patient's life, including the quality. How can clinicians best address this issue from a patient-centered perspective? What key takeaways should clinicians consider when constructing a management plan for chronic illnesses such as moderate to severe atopic dermatitis?

A celebrated molecular neuroscientist, Jeremy Nathans, MD, PhD, is responsible for landmark discoveries that have changed our understanding of how humans see the world. He is an investigator of the Howard Hughes Medical Institute and professor at Johns Hopkins University School of Medicine.  

The new editor-in-chief of JAMA and the JAMA Network, Kirsten Bibbins-Domingo, MD, PhD, discusses her transition from academic, physician-scientist to starting her new role at one of the most widely circulated general medical journals in the world. American Medical Association CXO Todd Unger hosts. Celebrate #WomenInMedicineMonth and learn more here: https://ama-assn.org/WomenMedicineMonth

In honor of Women in Medicine Month, Dr. Ludwig Lin interviews anesthesiologist and intensivist Sue Carlisle, MD, PhD, who recently retired as UCSF Dean for the Zuckerberg San Francisco General Hospital campus.  In this chat, Dr. Carlisle talks about her unconventional - yet entirely intentional - way she arrived at each step of her career, and talks about how her values system helped her develop her richly varied and successful academic career. It's an inspirational call for all of us to reach for the best versions of ourselves.   

Should the term "doctor" ONLY refer to those with a Medical Doctorate? --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app Support this podcast: https://anchor.fm/camthehumanist/support

Gideon And Being Used By God --- Jim Pirkle MD PhD 9/10/22 by Equipping The Saints

Hosts Gregg Masters and Fred Goldstein's guests are former CMS Administrator & FDA Commissioner and current Director and Robert J Margolis MD professor of business, medicine and health policy at the Margolis Center for Health Policy at Duke University, Mark McClellan MD PhD, and Paula Eichenbrenner, Executive Director of the AMCP Foundation. They discuss his receipt and significance of the Steven G Avey Award and the upside role of pharmacists in value based healthcare. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Dr. Holly Bauser-Heaton is an assistant professor and interventional pediatric cardiologist and physician-scientist at Sibley Heart Center at Children's Healthcare of Altanta. She is also a co-director of the MD-PhD program at Emory University. She earned her MD and PhD at Indiana University, completed residency in pediatrics at Cincinnati Children's Hospital, and fellowship at Lucile Salter Packard Children's Hospital at Stanford. Today she shares her journey to becoming a physician-scientist in a procedural field, and her thoughts on moving physician-scientist training forward as a co-director of an MSTP. Without further ado, here is my conversation with Dr. Holly Bauser-Heaton. Credits: Our thanks to Dr. Bauser-Heaton for being on the podcast. Follow Dr. Bauser-Heaton on twitter: @hbh_mdphd Dr. Bauser-Heaton's Faculty Page: https://www.pedsresearch.org/people/faculty/holly-bauser-heaton-md-phd Host: Bejan Saeedi Co-Host and Audio Engineer – Joe Behnke Executive Producer and Social Media Coordinator – Carey Jansen Executive Producer – Michael Sayegh Associate Producer – Josh Owens Faculty Advisors – Dr. Mary Horton and Dr. Brian Robinson Twitter: @behindthescope_ Instagram: @behindthemicroscopepod Facebook: @behindthemicroscope1 Website: behindthemicroscope.com

Dr. Ayana Jordan is a renowned expert in addiction and other mental health conditions, newly recruited to NYU to an endowed professorship for her fascinating research. For this episode of Flourishing After Addiction, I was excited to talk to her about new frontiers in her research, such as incorporating spirituality and health equity in addiction medicine. What I was not expecting was for her to share so openly and courageously about the way substance use problems have impacted her own family. It was a powerful conversation with a powerful voice in the field. It never fails to astonish me: the scope and reach of addiction into so many people's lives. Reading the stats is one thing, but to experience how it touches so many people, again and again, is truly striking.Ayana talks about her longstanding interest in integrating spirituality in addiction treatment, while simultaneously respecting people's values and beliefs, and doing so in a responsible and effective way. We discuss her work on harm reduction, racial justice, and health equity. She helps us think through how to work effectively with the social and structural determinants of health. And, we tackle the controversial question: what's the point of spirituality in the medical treatment of addiction in the first place?Ayana Jordan, MD PhD, is a renowned expert in addiction and other mental health conditions in underserved populations. She is the newly appointed Barbara Wilson Endowed Associate Professor of Psychiatry in the Department of Psychiatry at NYU, also with appointments and leadership positions in their department of Population Health, as well as NYU Langone's Institute for Excellence in Health Equity. The fundamental message of equity and inclusion has informed her research, clinical work, and leadership duties at NYU and beyond. She earned her MD PhD at Albert Einstein College of Medicine, and while training in the South Bronx, Dr. Jordan became passionate about serving racial and ethnic minoritized populations. She did her general adult psychiatry residency at Yale University, where she also served as chief resident. She has published dozens of peer-reviewed articles in numerous top-tier medical publications, serves on multiple editorial boards, and she is a thought leader who has given a wide range of keynote presentation both nationally and internationally. You can find her on her faculty page, Twitter, and Instagram.In this episode: - Information on naloxone (Narcan), including naloxone's availability in all 50 states.- Lancet Psychiatry profile of her- for more on her research, see many more of her publications linked on her NYU pageSign up for my newsletter and immediately receive my own free guide to the many pathways to recovery, as well as regular updates on new interviews, material, and other writings.

Knowing the exact outcome of any decision is something that many people wish for. Thankfully, life often does not allow this, or else we'd probably be bored out of our minds. In this episode of the Peak Performance Selling podcast, our host Jordan continues his conversation with Dr. Carla Fowler MD PhD about uncertainty, intentionality, and the one thing that successful people have in common.  HIGHLIGHTSUncertainty is part of what makes life more interesting Peak performance does not always mean working to the bone Be intentional in setting the pace of your work What do you do during your golden hours? What all successful people have in common  QUOTESDr. Carla on why uncertainty is not inherently bad: "If we're going to play a game, and if we already knew that you we're going to win, we wouldn't play the game. We'd be like, 'This is boring,' right? It robs the excitement."Dr. Carla on the one common thing about successful leaders she worked with: "I can recognize patterns that I want to go learn from, like who is really excelling at their field. And I will say, one thing that was very clear to me is that these leaders had very good clarity and the ability to communicate what results really matter here." You can connect with Dr. Carla and their work in the link below:LinkedIn - https://www.linkedin.com/in/carla-fowler/Website - https://www.thaxa.com/ If you're listening to the Peak Performance Selling Podcast, please subscribe, share, and send us your feedback.LinkedIn - https://www.linkedin.com/in/jordanbenjamin/Website - http://mycoreos.com/Podcast - https://www.mycoreos.com/podcastEmail - Jordan@MyCoreOS.comTwitter -https://twitter.com/jbenj09

As humans we prefer homeostasis. It's always easier to stay in your comfort zone. But as any self-made rich person might take you out, you need to take some risks. In this episode of the Peak Performance Selling podcast, our host Jordan Benjamin talks to THAXA's Managing Director, Dr. Carla Fowler MD PhD about the universal grind mindset and applying that to the 1-3-9 framework to figure out your company's goals and how you can boost performance.  HIGHLIGHTSTry to push yourself a little harderApplying the universal growth mindsetAdvice for executives wanting to boost performance Learn how to relish uncertainties Don't be afraid to run experiments Follow the 1-3-9 strategic framework QUOTESDr. Carla explains that the growth mindset applies to all aspects of life: The growth mindset isn't limited. You don't just get one bucket of it. You can use it in all areas of your life. It might take some thinking to kind of like transfer it but you can just say, ‘Hey, look at how capable I am over here.'"Dr. Carla discusses the need to make your work visible in the workplace: "A really interesting thing about influence is you can produce great results, but if people don't see them, it's like they didn't happen. And so the second piece is helping make your results visible. Sometimes that's some self promotion, sometimes that's making sure that the right people see it." Dr. Carla introduces her format for applying Performance Science Principles: "The 1-3-9 strategic framework is just a way to really clarify and distill it so it's like a one-page visual that they can look at and say, I know what my goal is, which is the one. I know what are the three most important critical priorities — think of those as the big gears that really drive you forwards. And then the nine is where we capture some of the detail in those priorities." You can connect with Dr. Carla and their work in the link below:LinkedIn - https://www.linkedin.com/in/carla-fowler/Website - https://www.thaxa.com/ If you're listening to the Peak Performance Selling Podcast, please subscribe, share, and send us your feedback.LinkedIn - https://www.linkedin.com/in/jordanbenjamin/Website - http://mycoreos.com/Podcast - https://www.mycoreos.com/podcastEmail - Jordan@MyCoreOS.comTwitter - https://twitter.com/jbenj09

Cardiovascular disease (CVD) is the number one cause of death globally, and nearly half of all U.S. adults are currently at risk for heart attack and stroke. Hossein Ardehali, MD, PhD, is working to understand the role of iron and metabolic processes in cardiovascular disease and develop new therapies that target iron accumulation in people with CVD and many other chronic diseases.

Performance Science is everywhere. From the sports arena to the business world, coaches are measuring every conceivable metric to determine what and how much can be improved to reach optimal performance. If you aren't doing this yet, then you're probably missing out. In this episode of the Peak Performance Selling podcast, our host Jordan Benjamin talks to THAXA's Managing Director, Dr. Carla Fowler MD PhD about the most common mistake that leaders make when it comes to performance. Dr. Carla also shares some best practices for effective goal-setting, and why you shouldn't set a goal that you know you can easily meet.  HIGHLIGHTSWhat is performance science? Top 3 common mistakes that leaders make Focus is essential to creating a successful process Best practices for effective goal-setting  QUOTESPerformance Science, according to Dr. Carla: "It is the multidisciplinary field that covers all of the different ideas and science that talk about how as human beings we do our best work or produce the best results. It has its origins in athletics -- that was one of the first places where we were really measuring performance. But pretty quickly, it merged into areas like the operating room, the cockpit, or the military."Dr. Carla on the most common mistake that leaders make: "Particularly as a leader if what is the goal is not clear, it becomes really challenging [not only] for your team to know how to win, but also for your team to judge their progress." You can connect with Dr. Carla and their work in the link below:LinkedIn - https://www.linkedin.com/in/carla-fowler/Website - https://www.thaxa.com/ If you're listening to the Peak Performance Selling Podcast, please subscribe, share, and send us your feedback.LinkedIn - https://www.linkedin.com/in/jordanbenjamin/Website - http://mycoreos.com/Podcast - https://www.mycoreos.com/podcastEmail - Jordan@MyCoreOS.comTwitter - https://twitter.com/jbenj09

* Want to know WHAT TRULY MATTERS when raising kids? *Leonard Sax, globally recognized Family Physician and Psychologist, shares what we should do, as parents, in the 21st-century to raise happy, healthy, and successful kids.This episode includes all his latest research about the following HOT topics:What's WRONG with today's parenting The effects of video games on kids The American culture of disrespect - music, tv & social mediaRules at home for managing screensCollege - does the school matter?Importance of developing virtue at home vs outsourcing to schoolsBooks he has authored:The Collapse of Parenting (Basic Books)Boys Adrift (Basic Books) – available in German as Jungs im Abseits (Kösel)Girls on the Edge (Basic Books)Why Gender Matters (Doubleday)Check out his website: www.leonardsax.com to access his most recent article “Why Culture Matters” and to find his speaking schedule. We highly recommend going to one of his talks, in person! Want tools for developing virtue in your kids, like Dr. Sax recommends? Check out our shop for products that bring this all to a practical level in your home - small daily actions that help your kids grow in Self Control, Respect, Responsibility, Gratitude, Generosity, Organization and Forgiveness! Interested in more topics like this about parenting? Join our mailing list! Each week we send an email newsletter with FREE resources that ease parenting stress, stories you can relate to, and valuable tips. Sign up today!And join our movement of like-minded parents who aren't willing to settle for the status quo.  Help us raise the bar in marriage and family life so we are raising happy, healthy, confident and successful kids who are able to bounce back from all our culture throws their way.  Join us inside our Private Facebook Group, The Thrive Community by Families of Character.

Carla Fowler, a DOUBLE DOCTOR (MD & PhD), believes you need to run good experiments in order to be a peak performer. A good experiment has two characteristics: 1. Look at the upside: what do I stand to gain, and what do I stand to lose? Ideally this scale is skewed in your favor where the potential for gain is significantly higher than the cost and potential of failure. 2. How am I going to learn something from this?  No matter how the experiment goes, it's important that you are ready to take away some learnings and apply it to future experiments and to be able to apply it to improve your own performance (or that of your product, family, team, or business). We covered so much ground and had such a great conversation in this episode, I know you'll love every minute of it!Carla has a special gift for my listeners! Check it out here: https://www.thaxa.com/p/your-personal-growth-personal-brand-podcast We also talked about: -How/why she got two doctorate level degrees -Don't just outwork your problems, do this instead -Why books are the most powerful learning tool in the world -Why sales doesn't have to be icky -The best way to make behavior change-And possibly the best parting wisdom so far on the show: "Go be bold, but not stupid." And so much more!  Connect with Carla: https://www.linkedin.com/in/carla-fowler/ And check out her website: https://www.thaxa.com/p/your-personal-growth-personal-brand-podcast Rate the podcast on iTunesConnect with me on LinkedInConnect with me on Facebook

Dr. Carla Fowler is an MD PhD and elite executive coach.  For the last decade, she has been a secret weapon for scores of CEOs, entrepreneurs, and other senior leaders.  Carla's unique approach combines the latest research from performance science with timeless best practices to help top performers level up and achieve their goals. https://www.thaxa.com/p/circuit-of-success... The post Carla Fowler Says 55-Mile Walk at 10-Years-Old Trained Her Feet for Surgical Residency in Adulthood appeared first on The Circuit of Success with Brett Gilliland.

Kaiser Permanente Bernard J. Tyson School of Medicine has been founded to educate future leaders in the transformation of healthcare delivery and addressing of health equity issues. During this Health View's episode, you'll hear from Mark Schuster, MD, PhD, the school's Founding Dean and CEO, which opened its doors and welcomed its inaugural class in July 2020. During this fascinating interview, Dr. Schuster proudly shares his passion for innovation, inclusivity, and commitment to improving the health and well-being of patients and communities by leading one of the most diverse medical schools in the nation. Listen on to also hear Dr. Schuster describe the school's core mission, vision and values, and its clinical learning which draws from the expertise of Kaiser Permanente.  

A review of five critical mental models that help individuals, teams and organizations perform under pressure.

Conversations with old friends warm the soul. This week my heart is full as I found myself catching up with my dear friend Dr. Eugene Schoenfeld and reminiscing about his "firsts" with mind-altering substances. We go back 57 years to hear about his experiences and journey with these substances, and how they changed the course of his life. Dr. Eugene Schoenfeld is a psychiatrist, author, lecturer, and popular underground newspaper columnist. He got his medical degree at the University of Miami School of Medicine, interned at Herrick Memorial Hospital (Berkeley, CA), and got his Master of Public Health from Yale University. While he has made a name for himself in the field of Psychology, you might know him better as "Dr. Hip". Dr. Eugene Schoenfeld wrote the popular underground column "Ask Dr. Hip" where people could submit their questions about sexuality and drugs. The anti-censorship philosophy that inspired the awakening of an underground press in the 1960s allowed Schoenfeld the freedom to answer those forbidden questions. He quickly became a popular source of reliable, common-sense information. Schoenfeld published his column from 1967 to 1973 and again from 1978 to 1979 in the underground, as well as in various mainstream newspapers including the Chicago Sun Times, Tampa Times, San Francisco Chronicle, and the San Francisco Examiner. Schoenfeld was a pioneering radio personality on Bay Area stations in the 1970s, and subsequent talk show doctors credit him for being a trailblazer. I, myself, was deeply inspired by Eugene's work. He is quite famous, and quite well liked, in the Bay Area for bringing medical science to popular newspapers.A true pioneer in advocating for the benefits of mind-altering medicine, Dr. Schoenfeld (AKA Dr. Hip) gets personal about his experiences with LSD and how his life has been enhanced in this week's new episode. Get full access to Mind Body Health & Politics at www.mindbodyhealthpolitics.org/subscribe

Have we learned anything from HIV or COVID? M4 Nathen, M2s Noah and Shana, and MD/PhD student Aline discuss the new epidemic of “Monkeypox,” and try to discern if our country has learned anything about how to respond to emerging diseases. A BMC Medical Education journal article shines some light on the best (and worst) study techniques med students use to drink from the firehose. Dave asks his co-hosts to celebrate an incoming class of med students by PIMPing each other…while wearing mouth spreaders.

Christian teaching

Doctors are one of the highest paid professions in America. But medical school does not teach doctors how to protect the wealth they accumulate, or how to keep financial privacy in their financial transactions. Very few doctors know how to manage or protect their wealth. Good news is that it's not overly complicated and whether … Continue reading Financial Freedom for Physician's Special with Dr. Christopher Loo, MD-PhD (Ep. 32) →

Race is commonly spoken of in medicine as a risk factor for diseases. It has even found its way into the equations that help doctors assess biological function. But race--commonly acknowledged these days as a social construct and not a biological one--really a valid way to factor in the differences between one patient and another? M3 Vijay and other students are helping lead the charge to re-assess these ideas. Also, MD/PHD students Aline, Levi, and Riley help listener Michelina decide what to do about her hair during interviews...and debate whether aspiring docs should even be worried about their physical look when applying.

Go online to PeerView.com/NEB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. How can recent advances in managing HER2-positive GI cancers be used to further improve outcomes for patients? With the validation of novel HER2-targeted agents in gastric, colorectal, and other GI malignancies, this has become the central therapeutic question—one that can be answered by a combination of evidence-based HER2 testing and the integration of modern HER2-directed therapeutics. In this activity, experts in HER-positive gastric cancer discuss the latest clinical evidence that supports the rapid integration of HER2-directed therapies across GI cancer settings. This “Seminars and Practicum” activity pairs compelling case discussion with the science that illustrates how to use innovative HER2 therapies to meaningfully improve patient outcomes—and the implication of this management model for EU and US practice. Don't miss this exciting, informative learning opportunity! Upon completion of this activity, participants should be better able to: Incorporate guideline-recommended HER2 testing into the routine management of patients with gastric, colorectal, and other GI tract cancers; Assess key safety and efficacy evidence on recently approved and emerging HER2-targeted therapies for different populations of patients with GI cancers; Develop individualized management plans for patients with HER2-positive GI cancers that leverage biomarker testing results, the latest clinical evidence, current guideline recommendations, and relevant patient-, disease- and treatment-specific factors; and Employ appropriate strategies and best practices to monitor for, mitigate, and manage AEs related to novel therapies for HER2-positive GI cancers.

Go online to PeerView.com/JPJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The modern management of multiple myeloma (MM) continues to be transformed by the emergence and further integration of different antibody-based approaches into patient management. How can professionals exploit these advances while using the principles of shared decision-making when caring for patients? In this activity, two hematologist-oncologists and a patient advocate explore these themes through a case-based discussion of novel antibody platforms in a range of MM treatment settings. Learners can expect insights on the safety and efficacy evidence supporting the use of antibody-based therapies in newly diagnosed and relapsed MM, along with practical guidance for safe delivery of care, and strategies for engaging with patients when developing treatment plans that include antibody components. Upon completion of this activity, participants should be better able to: Summarize current evidence and guideline recommendations surrounding the use of novel antibody platforms in multiple myeloma (MM); Integrate established and emerging antibody options, including monoclonal and bispecific antibodies, into treatment plans for patients with MM based on guideline recommendations and the latest clinical data; Address practical aspects of antibody therapy in MM, including unique safety considerations and effective sequential treatment; and Counsel patients with MM on dosing, safety, drug delivery, and therapeutic expectations with novel antibodies when engaging in shared decision-making discussions.

Go online to PeerView.com/NEB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. How can recent advances in managing HER2-positive GI cancers be used to further improve outcomes for patients? With the validation of novel HER2-targeted agents in gastric, colorectal, and other GI malignancies, this has become the central therapeutic question—one that can be answered by a combination of evidence-based HER2 testing and the integration of modern HER2-directed therapeutics. In this activity, experts in HER-positive gastric cancer discuss the latest clinical evidence that supports the rapid integration of HER2-directed therapies across GI cancer settings. This “Seminars and Practicum” activity pairs compelling case discussion with the science that illustrates how to use innovative HER2 therapies to meaningfully improve patient outcomes—and the implication of this management model for EU and US practice. Don't miss this exciting, informative learning opportunity! Upon completion of this activity, participants should be better able to: Incorporate guideline-recommended HER2 testing into the routine management of patients with gastric, colorectal, and other GI tract cancers; Assess key safety and efficacy evidence on recently approved and emerging HER2-targeted therapies for different populations of patients with GI cancers; Develop individualized management plans for patients with HER2-positive GI cancers that leverage biomarker testing results, the latest clinical evidence, current guideline recommendations, and relevant patient-, disease- and treatment-specific factors; and Employ appropriate strategies and best practices to monitor for, mitigate, and manage AEs related to novel therapies for HER2-positive GI cancers.

Go online to PeerView.com/JPJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The modern management of multiple myeloma (MM) continues to be transformed by the emergence and further integration of different antibody-based approaches into patient management. How can professionals exploit these advances while using the principles of shared decision-making when caring for patients? In this activity, two hematologist-oncologists and a patient advocate explore these themes through a case-based discussion of novel antibody platforms in a range of MM treatment settings. Learners can expect insights on the safety and efficacy evidence supporting the use of antibody-based therapies in newly diagnosed and relapsed MM, along with practical guidance for safe delivery of care, and strategies for engaging with patients when developing treatment plans that include antibody components. Upon completion of this activity, participants should be better able to: Summarize current evidence and guideline recommendations surrounding the use of novel antibody platforms in multiple myeloma (MM); Integrate established and emerging antibody options, including monoclonal and bispecific antibodies, into treatment plans for patients with MM based on guideline recommendations and the latest clinical data; Address practical aspects of antibody therapy in MM, including unique safety considerations and effective sequential treatment; and Counsel patients with MM on dosing, safety, drug delivery, and therapeutic expectations with novel antibodies when engaging in shared decision-making discussions.

Go online to PeerView.com/NEB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. How can recent advances in managing HER2-positive GI cancers be used to further improve outcomes for patients? With the validation of novel HER2-targeted agents in gastric, colorectal, and other GI malignancies, this has become the central therapeutic question—one that can be answered by a combination of evidence-based HER2 testing and the integration of modern HER2-directed therapeutics. In this activity, experts in HER-positive gastric cancer discuss the latest clinical evidence that supports the rapid integration of HER2-directed therapies across GI cancer settings. This “Seminars and Practicum” activity pairs compelling case discussion with the science that illustrates how to use innovative HER2 therapies to meaningfully improve patient outcomes—and the implication of this management model for EU and US practice. Don't miss this exciting, informative learning opportunity! Upon completion of this activity, participants should be better able to: Incorporate guideline-recommended HER2 testing into the routine management of patients with gastric, colorectal, and other GI tract cancers; Assess key safety and efficacy evidence on recently approved and emerging HER2-targeted therapies for different populations of patients with GI cancers; Develop individualized management plans for patients with HER2-positive GI cancers that leverage biomarker testing results, the latest clinical evidence, current guideline recommendations, and relevant patient-, disease- and treatment-specific factors; and Employ appropriate strategies and best practices to monitor for, mitigate, and manage AEs related to novel therapies for HER2-positive GI cancers.

Go online to PeerView.com/JPJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The modern management of multiple myeloma (MM) continues to be transformed by the emergence and further integration of different antibody-based approaches into patient management. How can professionals exploit these advances while using the principles of shared decision-making when caring for patients? In this activity, two hematologist-oncologists and a patient advocate explore these themes through a case-based discussion of novel antibody platforms in a range of MM treatment settings. Learners can expect insights on the safety and efficacy evidence supporting the use of antibody-based therapies in newly diagnosed and relapsed MM, along with practical guidance for safe delivery of care, and strategies for engaging with patients when developing treatment plans that include antibody components. Upon completion of this activity, participants should be better able to: Summarize current evidence and guideline recommendations surrounding the use of novel antibody platforms in multiple myeloma (MM); Integrate established and emerging antibody options, including monoclonal and bispecific antibodies, into treatment plans for patients with MM based on guideline recommendations and the latest clinical data; Address practical aspects of antibody therapy in MM, including unique safety considerations and effective sequential treatment; and Counsel patients with MM on dosing, safety, drug delivery, and therapeutic expectations with novel antibodies when engaging in shared decision-making discussions.

Go online to PeerView.com/JPJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. The modern management of multiple myeloma (MM) continues to be transformed by the emergence and further integration of different antibody-based approaches into patient management. How can professionals exploit these advances while using the principles of shared decision-making when caring for patients? In this activity, two hematologist-oncologists and a patient advocate explore these themes through a case-based discussion of novel antibody platforms in a range of MM treatment settings. Learners can expect insights on the safety and efficacy evidence supporting the use of antibody-based therapies in newly diagnosed and relapsed MM, along with practical guidance for safe delivery of care, and strategies for engaging with patients when developing treatment plans that include antibody components. Upon completion of this activity, participants should be better able to: Summarize current evidence and guideline recommendations surrounding the use of novel antibody platforms in multiple myeloma (MM); Integrate established and emerging antibody options, including monoclonal and bispecific antibodies, into treatment plans for patients with MM based on guideline recommendations and the latest clinical data; Address practical aspects of antibody therapy in MM, including unique safety considerations and effective sequential treatment; and Counsel patients with MM on dosing, safety, drug delivery, and therapeutic expectations with novel antibodies when engaging in shared decision-making discussions.

Dr. Mark Mullins is a neuroradiologist and professor Department of Radiology and Imaging Sciences at Emory University. In addition to his clinical responsibilities, he also serves as the Vice-chair for education within the department and as well as the Director of Radiology Medical Student Education. Prior to joining the faculty at Emory, Dr. Mullins completed his undergraduate and graduate training in chemistry at Harvard University and his medical education as part of the Harvard MIT program in Health Sciences and Technology. He then completed his diagnostic radiology residence and neuroradiology fellowship at Massachusetts General Hospital. Since joining the faculty at Emory, Dr. Mullins has remained actively involved with medical education, including having previously served as the diagnostic radiology residency program director. He also holds numerous teaching and mentorship awards received throughoutthe years, including the 2020 Radiological Society of North America's Outstanding Educator Award. In today's episode, we discuss several important educational initiatives of his during his time at Emory, including the creation of the Emory research-track residency program. We also discuss important transitions throughout/phd and physician-scientist training. Credits: Our thanks to Dr. Mullins for being on the podcast. Follow Dr. Mullins on twitter: @markemullins Dr. Mullins' faculty page: https://winshipcancer.emory.edu/bios/faculty/mullins-mark-e.html Host: Bejan Saeedi Co-Host and Audio Engineer – Joe Behnke Executive Producer and Social Media Coordinator – Carey Jansen Executive Producer – Michael Sayegh Associate Producer – Josh Owens Faculty Advisor – Dr. Brian Robinson Twitter: @behindthescope_ Instagram: @behindthemicroscopepod Facebook: @behindthemicroscope1 Website: behindthemicroscope.com

Dr. Carla Fowler is an MD PhD and elite executive coach. For the last decade, she has been a secret weapon for scores of CEOs, entrepreneurs, and other senior leaders. Carla's unique approach combines the latest research from performance science with timeless best practices to help top performers level up and achieve their goals. Learn more about your ad choices. Visit megaphone.fm/adchoices

If you want to know more about Medical Scientist Training Programs (MD/PhD), then this is the episode for you! You will hear from a leader in the MSTP community, Mr. Brian Sullivan, the Executive Director of the MSTP at Washington University School of Medicine in St. Louis.  As Director of the largest MSTP in the US, Mr. Sullivan brings a wealth of knowledge as he walks us through the intricacies of this unique biomedical research training degree and discusses some of the little known and subtle nuances of what makes for a strong MSTP applicant.  If you find this podcast to be a helpful resource, RATE, REVIEW, & SUBSCRIBE please!  It helps others find it! Send me your recommendations for future medical schools that you'd like to hear featured! Send it to: allaccess@case.edu    Visit our website for more information on this episode and others.  https://linktr.ee/allaccessmedschool     RESOURCES:  Washington University School of Medicine MSTP CWRU School of Medicine MSTP List of MSTP Programs AAMC MSTP Resources AAMC Tools for MSTP Applicants Gaps between college and starting an MD-PhD program are adding years to physician-scientist training time Long-Term Trends in the Age of Principal Investigators Supported for the First Time on NIH R01-Equivalent Awards CONTACT:  mstp@email.wustl.edu 

August 5, 2022. Stem cell expert David Gamm, MD, PhD, talks with host Ben Shaberman about his innovative work in stem cell therapy development for retinal diseases, including his research at the University of Wisconsin-Madison and the company Opsis, which he co-founded. Their conversation covers a variety of topics including induced pluripotent stem cells, the benefits of scaffolds for cell orientation in the retina, and scale-up manufacturing.

Erkeda DeRouen is joined by Dr. Ram Rao, a physician scientist, and Pediatric Hematology Oncology Fellow at Stanford University. In this episode, he gives advice on doing MD/PhDs and what to do when switching specialties. [00:44] Introducing Dr. Rao [03:56] Process of Doing MD/PhD [05:40] Advise on Switching Specialties [12:20] Passions Outside of Medicine [14:27] Dr. Rao's Best Piece of Advice Full show notes

In this episode Dr. Maxwell Cooper interviews Dr. Lars Svensson, a cardiothoracic surgeon and the Heart & Vascular Institute Chair at Cleveland Clinic. Dr. Svensson is an expert in aortic surgery and minimally invasive techniques, including percutaneous transcatheter aortic valve replacement (TAVR). He was a PI for the groundbreaking PARTNER clinical trials that established TAVR as a safe and effective treatment option for patients with aortic valve disease. Dr. Svensson tells the listeners about his days as surgical resident learning under giants in cardiothoracic surgery, including Dr. Christian Barnard - the first surgeon to perform a human heart transplant, and the world renowned Dr. Michael DeBakey. He gives an overview of his clinical practice as a cardiothoracic surgeon and his responsibilities as the Heart and Vascular Institute Chair at Cleveland Clinic. Additionally, he discusses how Cleveland Clinic has been able to remain the #1 ranked heart hospital in the world for the last 28 consecutive years and the future of cardiovascular healthcare. Dr. Svensson describes his innovative process that has lead to many new techniques and devices for aortic surgery and percutaneous valve replacement. Lastly, Dr. Svensson provides advice for residents and medical students on how they can make innovative contributions to medicine. *Views expressed in this podcast are those of the individuals, not their respective institutions   The DaVinci Hour Podcast Website: https://www.dviacademy.com/the-davinci-hour DaVinci Academy Website: https://www.dviacademy.com/ 20% off Discount Code (TDH20) for DaVinci Academy's online video courses for Anatomy, Histology, and Biochemistry available at https://www.dviacademy.com/store YouTube: https://www.youtube.com/c/DaVinciAcademyMed/ Twitter: https://twitter.com/DviAcademy Instagram: https://www.instagram.com/davinci_academy1/ Facebook: https://www.facebook.com/dviacademy LinkedIn: https://www.linkedin.com/company/davinci-academy---dviacademy.com

Conversations with old friends warm the soul. This week my heart is full as I found myself catching up with my dear friend Dr. Eugene Schoenfeld and reminiscing about his "firsts" with mind-altering substances. We go back 57 years to hear about his experiences and journey with these substances, and how they changed the course of his life. Dr. Eugene Schoenfeld is a psychiatrist, author, lecturer, and popular underground newspaper columnist. He got his medical degree at the University of Miami School of Medicine, interned at Herrick Memorial Hospital (Berkeley, CA), and got his Master of Public Health from Yale University. While he has made a name for himself in the field of Psychology, you might know him better as "Dr. Hip". Dr. Eugene Schoenfeld wrote the popular underground column "Ask Dr. Hip" where people could submit their questions about sexuality and drugs. The anti-censorship philosophy that inspired the awakening of an underground press in the 1960s allowed Schoenfeld the freedom to answer those forbidden questions. He quickly became a popular source of reliable, common-sense information. Schoenfeld published his column from 1967 to 1973 and again from 1978 to 1979 in the underground, as well as in various mainstream newspapers including the Chicago Sun Times, Tampa Times, San Francisco Chronicle, and the San Francisco Examiner. Schoenfeld was a pioneering radio personality on Bay Area stations in the 1970s, and subsequent talk show doctors credit him for being a trailblazer. I, myself, was deeply inspired by Eugene's work. He is quite famous, and quite well liked, in the Bay Area for bringing medical science to popular newspapers.A true pioneer in advocating for the benefits of mind-altering medicine, Dr. Schoenfeld (AKA Dr. Hip) gets personal about his experiences with LSD and how his life has been enhanced in this week's new episode.

The brain is a fascinating and complex organ. It's the primary control center for our whole body, and it can be affected by stress in many different ways. Stress itself is an important part of life – it helps us prepare for danger or respond to emergencies. But when we're constantly stressed out, that's when our brain starts to pay the price. This blog post will explore how stress affects your brain, both positively and negatively, so you can develop strategies to reduce your brain's vulnerability to its harmful effects.In this episode I speak with Dr Mithu Storoni, an eye surgeon & neuroscience researcher-turned writer. She is the author of "Stress Proof". This episode taught me so much about the neurobiology of stress and how to combat stress in your life. Find Mithu here:InstagramHer websiteStress Proof BookKETONE-IQ- 20% DISCOUNT - NEUROhttps://hvmn.me/NeuroYou can follow me or contact me here ---Newsletter: https://bit.ly/3ewI5P0Instagram: louisanicola_Twitter : louisanicola_YouTube: Louisa NicolaThe information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Neuro Experience podcast, its employees, guests and affiliates assume no liability for the application of the information discussed.